| Page | |
|---|---|
| Balance Sheet | 1—2 |
| Notes to the Financial Statements | 3—4 |
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| FIXED ASSETS | |||||
| Investments | 4 |
|
|
||
|
|
|
||||
| CURRENT ASSETS | |||||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 5 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
( |
( |
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
|||
| Creditors: Amounts Falling Due After More Than One Year | 6 |
( |
( |
||
| NET LIABILITIES |
( |
( |
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 7 |
|
|
||
| Profit and Loss Account |
( |
( |
|||
| SHAREHOLDERS' FUNDS | (1,880) | (980) | |||
|
Director
|
|
|
| Other | |
|---|---|
| £ | |
| Cost or Valuation | |
| As at 1 November 2024 |
|
| Additions |
|
| As at 31 October 2025 |
|
| Provision | |
| As at 1 November 2024 |
|
| As at 31 October 2025 |
|
| Net Book Value | |
| As at 31 October 2025 |
|
| As at 1 November 2024 |
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Other creditors | 900 | 4,680 | |
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Other creditors | 212,609 | 109,722 | |
Director
The company director has provided funds during the period on an unsecured interest free basis and repayable on demand. The balance owed to the director at 31 October 2025 amounted to £Nil (2024: £3,900)
Vivo Medica Ltd
The director has a significant interest in Vivo Medica Ltd
Vivo Medica Ltd has provided funds during the period on an unsecured interest free basis and repayable after more than one year. The balance owed to Vivo Medica Ltd at 31 October 2025 amounted to £212,609 (2024: £109,722)